DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017 年 04 月 24 日 7:30 上午 - 2017 年 04 月 26 日 12:00 下午

1750 Rockville Pike, , Rockville, MD 20852 , USA

CMC Workshop

Session 9C: Regional Updates – Part 3: Middle East

Session Chair(s)

Ihab  Attia

Ihab Attia

Regulatory Director

Eli Lilly and Company, United Arab Emirates

This session will provide an overview and update about the regulatory landscape in the Middle East, with main focus on challenges and opportunities. It will reflect the updated accelerated programs implemented recently in the region and sharing successful stories. It will address as well the current post-approval CMC changes model, the specificity of the local requirement linked to the complex supply management and patient access implication, with an industry proposal for future trend to optimize the life cycle maintenance activity of the registered products.

Speaker(s)

Ihab  Attia

Speaker

Ihab Attia

Eli Lilly and Company, United Arab Emirates

Regulatory Director

Inas  Chehimi

Speaker

Inas Chehimi

Novartis Pharma Services AG, United Arab Emirates

Head Regulatory Affairs - Middle East & North Africa

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。